Harvard technology to be commercialized by Vesigen Therapeutics

The startup company Vesigen will develop and commercialize the drug-delivery technology created in the lab of Harvard Chan School Professor Quan Lu.

Caroline Perry • harvard
July 22, 2020 ~10 min

Tags: science-technology harvard-th-chan-school-of-public-health office-of-technology-development quan-lu caroline-perry armms arrdc1-mediated-microvesicles blavatnik-biomedical-accesserator large-molecule-drugs vesigen-therapeutics

Major study on Duchenne muscular dystrophy gains support

Harvard stem-cell research receives support from Sarepta Therapeutics for work on Duchenne muscular dystrophy.

Caroline Perry • harvard
Jan. 9, 2020 ~6 min

Tags:  science-technology  stem-cells  office-of-technology-development  amy-wagers  caroline-perry  duchenne-muscular-dystrophy  sarepta-therapeutics

Page 1 of 1